| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 01/13/2003 | WO2002006237A1 Medicine comprising dicyanopyridine derivative |
| 01/13/2003 | CA2415899A1 Medicine comprising dicyanopyridine derivative |
| 01/09/2003 | WO2003002567A1 New pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections |
| 01/09/2003 | WO2003002561A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/09/2003 | WO2003002558A1 Remedial agent for viral infectious disease |
| 01/09/2003 | WO2003002557A1 Novel compounds for use as photoinitiators |
| 01/09/2003 | WO2003002556A1 Novel heteroaryl derivatives, their preparation and use |
| 01/09/2003 | WO2003002552A1 Novel indole derivatives |
| 01/09/2003 | WO2003002544A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/09/2003 | WO2003002540A1 Cyclic diamine compound having five-membered cyclic group |
| 01/09/2003 | WO2003002537A1 Bis(5-aryl-2-pyridyl) derivative |
| 01/09/2003 | WO2003002534A1 Bis-piperidines |
| 01/09/2003 | WO2003002533A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 01/09/2003 | WO2003002532A1 Cyclic diamine compounds having fused-ring groups |
| 01/09/2003 | WO2003002531A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002530A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002122A1 Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease |
| 01/09/2003 | WO2002087587A3 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors |
| 01/09/2003 | WO2002059111A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/09/2003 | WO2002022579A3 Antipsychotic sulfonamide-heterocycles, and methods of use thereof |
| 01/09/2003 | WO2001068637A3 Method for the preparation of tetrahydrobenzothiepines |
| 01/09/2003 | US20030009039 Reacting a beta -lactam with an alkoxide to form substituted isoserine ester compound |
| 01/09/2003 | US20030008909 For therapy of uterine myometrial fibroids, endometriosis, benign prostatic hypertrophy; carcinomas and adenocarcinomas of endometrium, ovary, breast, colon, prostate, pituitary, meningioma and other hormone-dependent tumors |
| 01/09/2003 | US20030008901 For therapy of arthritis, cancer, and other diseases characterized by matrix metalloproteinase or mammalian reprolysin activity |
| 01/09/2003 | US20030008898 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation |
| 01/09/2003 | US20030008896 Isoquinolinone derivatives |
| 01/09/2003 | US20030008888 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/09/2003 | US20030008883 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 01/09/2003 | US20030008877 CCR5 antagonists useful for treating AIDS |
| 01/09/2003 | CA2452039A1 Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease |
| 01/09/2003 | CA2451464A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/09/2003 | CA2451228A1 Novel heteroaryl derivatives, their preparation and use |
| 01/09/2003 | CA2451128A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/09/2003 | CA2451125A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/09/2003 | CA2450722A1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/08/2003 | EP1273582A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 01/08/2003 | EP1273575A1 Diazepane derivatives or salts thereof |
| 01/08/2003 | EP1273572A1 Thiophene substituted piperazines useful in the treatment of benign prostatic hyperplasia |
| 01/08/2003 | EP1273571A1 Nitrogenous compounds and antiviral drugs containing the same |
| 01/08/2003 | EP1272474A1 Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/or treatment of anemias |
| 01/08/2003 | EP1272193A2 Synergistic methods and compositions for treating cancer |
| 01/08/2003 | EP1272168A2 Small organic molecule regulators of cell proliferation |
| 01/08/2003 | EP0996439B1 Beta-alkoxyacrylates against malaria |
| 01/08/2003 | CN1390206A Inhibitors of factor Xa |
| 01/08/2003 | CN1390205A Novel compound |
| 01/08/2003 | CN1390204A Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/08/2003 | CN1390201A Cyclic amine compounds as CCR5-antagonists |
| 01/08/2003 | CN1390200A Inhibitors of metalloproteinases |
| 01/08/2003 | CN1098264C Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases |
| 01/08/2003 | CN1098263C Pyridin-2-yl-methylaminederivatives, method of preparing and application as medicine |
| 01/08/2003 | CN1098260C 2,4-diaminopyrimidine derivatives |
| 01/07/2003 | US6504036 2- and 2.5-substituted phenylketoenols |
| 01/07/2003 | US6503949 Glucagon antagonists/inverse agonists |
| 01/07/2003 | US6503935 Imidazoles and related compounds as α1A agonists |
| 01/07/2003 | US6503926 Nitrogen heterocycle compounds |
| 01/07/2003 | US6503917 Post-menopause, atherosclerosis, osteoporosis, and Alzheimer*s disease treatment |
| 01/07/2003 | US6503905 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/07/2003 | US6503901 Amino lactam sulfonamides as inhibitors of Aβ protein production |
| 01/07/2003 | US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection |
| 01/07/2003 | CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease |
| 01/07/2003 | CA2075684C 1-acylpiperidine compounds |
| 01/05/2003 | CA2392189A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 01/03/2003 | WO2003000692A2 Oxytocin agonists |
| 01/03/2003 | WO2003000679A2 Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators |
| 01/03/2003 | WO2003000666A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000663A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000660A1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 01/03/2003 | WO2003000267A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 01/03/2003 | WO2003000251A1 Novel idolinones and uses thereof |
| 01/03/2003 | WO2003000250A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2002083667A3 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/03/2003 | WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 01/03/2003 | CA2455292A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | CA2454538A1 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same |
| 01/03/2003 | CA2451354A1 Herbicidal substituted pyridines, their preparation, and their use as herbicides and plant growth regulators |
| 01/03/2003 | CA2451249A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 01/03/2003 | CA2450579A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | CA2450491A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | CA2450480A1 Oxytocin agonists |
| 01/03/2003 | CA2450475A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | CA2449441A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 01/02/2003 | US20030004354 Thienylsulphonylamino(thio)carbonyl compounds |
| 01/02/2003 | US20030004181 Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions |
| 01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004156 Anticholesterol agents; cardiovascular disorders; antidiabetic agents; antiproliferative agents |
| 01/02/2003 | US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents |
| 01/02/2003 | US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light |
| 01/02/2003 | EP1270570A1 Amide compounds and use thereof |
| 01/02/2003 | EP1270569A1 Substituted tryptophan derivatives |
| 01/02/2003 | EP1270568A1 1-methyl-4-(3-ethoxy-9h-thioxanthene-ylidene)-piperidine and its use as 5-HT2B and/or H1 antagonist |
| 01/02/2003 | EP1270557A1 Ethylenediamine derivatives |
| 01/02/2003 | EP1268484A1 Condensed imidazoles as histamine h3 receptor ligands |
| 01/02/2003 | EP1268469A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 01/02/2003 | EP1268444A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/02/2003 | EP1268435A1 4,5-dihydro-1h-pyrazole derivatives having cb 1-antagonistic activity |
| 01/02/2003 | EP1268431A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 01/02/2003 | EP1268428A2 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |